Agilon Health Stock Set to Reverse Split on Tuesday, March 31st (NYSE:AGL)

Agilon Health, Inc. (NYSE:AGL) shares are going to reverse split before the market opens on Tuesday, March 31st. The 1-25 reverse split was announced on Wednesday, March 18th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 30th.

Agilon Health Stock Down 18.7%

AGL traded down $0.11 on Thursday, reaching $0.48. The company’s stock had a trading volume of 6,375,500 shares, compared to its average volume of 6,935,547. The company has a market capitalization of $199.14 million, a price-to-earnings ratio of -0.51 and a beta of 0.11. Agilon Health has a fifty-two week low of $0.34 and a fifty-two week high of $6.08. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a 50 day moving average of $0.69 and a two-hundred day moving average of $0.80.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.46 billion. Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%. As a group, analysts forecast that Agilon Health will post -0.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AGL has been the topic of several research reports. BTIG Research reaffirmed a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Barclays cut their price target on Agilon Health from $1.00 to $0.50 and set an “underweight” rating on the stock in a research report on Friday, February 27th. Royal Bank Of Canada upgraded Agilon Health from a “hold” rating to a “moderate buy” rating in a research note on Wednesday, December 3rd. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. Finally, Wells Fargo & Company lifted their target price on shares of Agilon Health from $1.00 to $1.50 and gave the company an “overweight” rating in a report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus target price of $2.18.

Hedge Funds Weigh In On Agilon Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. CenterBook Partners LP grew its holdings in Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after acquiring an additional 9,499,012 shares during the period. Geode Capital Management LLC boosted its position in shares of Agilon Health by 2.6% during the 2nd quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company’s stock worth $16,462,000 after purchasing an additional 178,477 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Agilon Health by 60.1% during the 2nd quarter. SG Americas Securities LLC now owns 230,912 shares of the company’s stock worth $531,000 after purchasing an additional 86,723 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Agilon Health by 583.2% during the 2nd quarter. XTX Topco Ltd now owns 400,760 shares of the company’s stock worth $922,000 after purchasing an additional 342,100 shares during the period. Finally, Norges Bank purchased a new position in shares of Agilon Health in the 2nd quarter valued at about $3,299,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.